Quarterly report pursuant to Section 13 or 15(d)

SHAREHOLDERS EQUITY (DEFICIT) - Stock Options (Details)

v3.23.4
SHAREHOLDERS EQUITY (DEFICIT) - Stock Options (Details) - Stock options - $ / shares
9 Months Ended 12 Months Ended
Sep. 30, 2023
Dec. 31, 2022
Dec. 31, 2021
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]      
Options at beginning of period (in shares) 49,040 60,212  
Options granted (in shares) 10,000 6,500  
Options exercised (in shares)   (40)  
Options canceled / expired (in shares) (15,950) (17,632)  
Options at end of period (in shares) 43,090 49,040 60,212
Options vested and exercisable as at end of the period 30,567    
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract]      
Exercise Price at beginning of period (in dollars per share) $ 129.60 $ 111.20  
Options granted (in dollars per share) 0.86 103.20  
Options exercised (in dollars per share)   100.80  
Options canceled / expired (in dollars per share) 126.25 50.20  
Exercise Price at end of period (in dollars per share) 101.25 $ 129.60 $ 111.20
Exercise Price vested and exercisable (in dollars per share) $ 125.83    
Share-based Compensation Arrangement by Share-based Payment Award, Options, Additional Disclosures [Abstract]      
Weighted Average Remaining Contractual Life (in years) 2 years 6 months 2 years 9 months 18 days 3 years 7 months 6 days
Weighted Average Remaining life vested and exercisable (in years) 1 year 10 months 24 days